Usefulness of a simplified scoring system to predict early non-relapse mortality after stem cell transplantation

被引:0
|
作者
Balsalobre, P. [1 ]
Munoz, C. [1 ]
Serrano, D. [1 ]
Gayoso, J. [1 ]
Rodriguez, G. [1 ]
Buno, I. [1 ]
Martinez, Y. [1 ]
Gomez-Pineda, A. [1 ]
Diez-Martin, J. L. [1 ]
机构
[1] Univ Gregorio Maranon, Gen Hosp, Madrid, ES, Spain
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S172 / S172
页数:1
相关论文
共 50 条
  • [31] Citrulline Trajectory during Allogeneic Hematopoietic Stem Cell Transplantation Is Correlated to Conditioning Intensity and Non-Relapse Mortality
    Gomes, Christopher Nunes
    Seegers, Valerie
    Schmidt, Aline
    Orvain, Corentin
    Villate, Alban
    Bouvier, Anne
    Simard, Gille
    Del Galy, Aurelien Sutra
    Francois, Sylvie
    Giltat, Aurelien
    Robin, Jean Baptiste
    Delneste, Yves
    Ifrah, Norbert
    Hunault, Mathilde
    Thepot, Sylvain
    BLOOD, 2020, 136
  • [32] Failure to Recover Thymopoiesis After Allogeneic Hematopoietic Stem Cell Transplantation Predicts for High Incidence of Opportunistic Infections and Non-Relapse Mortality
    Wils, Evert-Jan
    van der Holt, Bronno
    Broers, Annoek E. C.
    Posthumus-van Sluijs, Sandra J.
    Gratama, Jan W.
    Braakman, Eric
    Cornelissen, Jan J.
    BLOOD, 2010, 116 (21) : 362 - 363
  • [33] Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors
    Arrieta-Bolanos, Esteban
    Mayor, Neema P.
    Marsh, Steven G. E.
    Madrigal, J. Alejandro
    Apperley, Jane F.
    Kirkland, Keiren
    Mackinnon, Stephen
    Marks, David I.
    McQuaker, Grant
    Perry, Julia
    Potter, Michael N.
    Russell, Nigel H.
    Thomson, Kirsty
    Shaw, Bronwen E.
    HAEMATOLOGICA, 2016, 101 (03) : 382 - 390
  • [34] Treosulfan conditioning for allogenic hematopoietic stem cell transplantation in multiple myeloma, advantages for non-relapse mortality and survival, but with high incidence of relapse
    Gran, Charlotte
    Wang, Junfeng
    Nahi, Hareth
    Koster, Linda
    Einsele, Herman
    Itala-Remes, Maija
    Holler, Ernst
    Beelen, Dietrich
    Ciceri, Fabio
    Ehninger, Gerhard
    Finke, Juergen
    de Wreede, Liesbeth
    Ljungman, Per
    Tischer, Johanna
    Verbeek, Mareike
    Klyuchnikov, Evgeny
    Hilgendorf, Inken
    Schaefer-Eckart, Kerstin
    Scheid, Christof
    Bunjes, Donald
    Basara, Nadezda
    Haenel, Mathias
    Mueller, Lutz Peter
    Biersack, Harald
    Gahrton, Gosta
    Garderet, Laurent
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2018, 53 : 659 - 660
  • [35] Elevated plasma level of thrombomodulin early after allogeneic haematopoietic stem cell transplantation is associated with severe acute GVHD and increased risk of non-relapse mortality.
    Takeda, J.
    Aoki, K.
    Maruyama, K.
    Kazuma, Y.
    Nagahata, Y.
    Funayama, Y.
    Yamauchi, N.
    Ono, Y.
    Kato, A.
    Tabata, S.
    Matsushita, A.
    Hashimoto, H.
    Shimizu, N.
    Ishikawa, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S179 - S179
  • [36] Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation
    Masamitsu Yanada
    Naoyuki Uchida
    Tatsuo Ichinohe
    Takahiro Fukuda
    Junya Kanda
    Yoshinobu Kanda
    Yoshiko Atsuta
    Hideki Nakasone
    Bone Marrow Transplantation, 2021, 56 : 1720 - 1722
  • [37] Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation
    Yanada, Masamitsu
    Uchida, Naoyuki
    Ichinohe, Tatsuo
    Fukuda, Takahiro
    Kanda, Junya
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Nakasone, Hideki
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1720 - 1722
  • [38] Pretransplant serum FT3 levels in recipients predict early non-relapse mortality after myeloablative allogeneic haematopoietic cell transplantation from matched sibling donors
    Li, Huijuan
    Chen, Jia
    Shi, Bimin
    Chen, Xingbo
    Wu, Depei
    Wang, Ying
    HEMATOLOGY, 2018, 23 (01) : 38 - 43
  • [39] IMPACT OF REDUCTION IN GVHD-RELATED MORTALITY FOR RECENT IMPROVEMENT OF NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S288 - S289
  • [40] IMPROVED NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OVER 3 DECADES: A SINGLE-INSTITUTION HISTORICAL EXPERIENCE
    Malard, F.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Legouill, S.
    Harrousseau, J. -L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S86 - S86